Elderly patients with hip fracture experience high morbidity and mortality, and are often undertreated for pain. Acute pain management in the elderly is challenging, with physiological frailty, medical comorbidities and cognitive impairment commonly compounding pain assessment and treatment. Guidelines outlining current best practice for acute pain management in the elderly now exist, but evidence suggests that practice remains variable and there continues to be scope for improvement. We conducted a narrative review of the literature to examine the challenges of acute pain management in the elderly, and to evaluate evidence for the role of regional nerve blocks for acute pain associated with hip fracture in the elderly. There is consistent evidence that regional nerve blocks can effectively reduce pain associated with hip fracture, providing rapid-onset, site-specific analgesia that is more effective than standard systemic analgesia alone. There is also moderate evidence that nerve blocks may contribute to reduced rates of delirium, and some suggestion of reduced length of inpatient stay, morbidity and mortality, although limited evidence is available. Fascia iliaca blocks are emerging as a block of choice, with evidence they can be safely and rapidly administered under ultrasound guidance in the acute setting, by both trained medical and nursing staff, with good effect. Ideally, comprehensive pain protocols for elderly hip fracture patients are required, that integrate evidence-based fascia iliaca block use, timely and repeated pain assessment, and multidisciplinary orthogeriatric patient care.
Introduction
Hip fracture (fractured neck of femur) is an increasingly common emergency surgical presentation [1, 2] and a rising social and economic burden [3] . Economically, the annual cost of proximal femoral fracture in the UK alone is projected to be between £3.6 and 5.6 billion per annum (inflation adjusted) by the year 2033 [2] . This reflects the high morbidity and mortality of the condition, particularly among the frail elderly [2, 4, 5] . According to published guidelines from the Association of Anaesthetists of Great Britain and Ireland (AAGBI), 8-10% of patients die within 30 days of hip fracture, and typically 15-30% of patients die within a year of surgery [6] . This can vary across patient cohorts, with one prospective hospital audit reporting that 43 .1% of patients died in the first year and 75% died within five years of hip fracture [5] . A number of variables have been shown to be predictive of hip fracture mortality, including: advanced age; cognitive dysfunction; the inability to independently mobilise; and premorbid functional dependence [5] . Of these, advanced age and poor cognitive function appeared to be associated with the greatest relative risk of five-year mortality [5] . Since the hip fracture population has a median age over 80 years, and approximately one-third of patients demonstrate significant cognitive impairment at presentation [3] , high mortality among elderly hip fracture patients is likely to be an ongoing issue.
In a previous retrospective database review, patients aged > 85 years with hip fracture demonstrated a greater incidence of complications and an increased length of stay, compared with those < 85 years [7] . Odds ratios were significantly increased for lower respiratory tract infection, myocardial infarction and acute renal failure for those aged > 85 years (OR 1.58, 1.67 and 1.54, respectively). Length of stay was also significantly longer, at a median of 18 days (compared with 15 days for those < 85 years) [7] . Only one in three older people who survive a hip fracture return to their previous level of independence, 50% require long-term assistance with routine activities and cannot walk unaided, and 25% require fulltime nursing home care [8] .
The functional decrement, as well as the high rates of morbidity and mortality, highlights the need to reduce modifiable risks to mortality wherever possible. It has been suggested that up to 50% of postoperative deaths following hip fracture are potentially avoidable [9] , demonstrating considerable room for improvement in the management of the elderly hip fracture population.
Globally, many organisations and policy makers have recognised the need for improvement in quality of care for the elderly hip fracture patient, producing guidelines in Australia [10] , the UK [6, 11] and the US [12] . In particular, there is growing recognition of the importance of optimal pain management in the important peri-operative period. Pain management can be particularly challenging in the physiologically frail and elderly, and the acute trauma setting [13] . This narrative review describes the unique challenges of acute pain management in the elderly, and reviews evidence for the use of regional nerve blockade to provide analgesia after hip fracture in the elderly.
Methods
For this narrative review, we conducted a literature search of the PubMed, Ovid Medline and Cochrane databases in May 2017 to identify relevant published clinical trials, clinical audits, review articles and metaanalyses up to that date. Key search terms included: 'fractured neck of femur'; 'hip fracture'; 'elderly'; 'acute pain'; 'nerve block'; 'fascia iliaca block'; 'delirium'; 'pain protocol'; and 'pain pathway'. Articles were considered if they were published in English, and were excluded if they recruited children (< 18 years). We read the abstracts of retrieved citations to identify relevant articles to review in their entirety. Reviewed literature was critically evaluated using the Evidence Hierarchy of the National Health and Medical Research Council of Australia [14] . Two authors independently graded the level of evidence presented in each paper, and a third author reviewed for consensus. There was 100% inter-rater concordance for all reviewed studies, with no discrepancies between authors identified.
Pain in acute hip fracture
Severe pain increases morbidity associated with hip fracture. Patients who experience greater pain have a higher risk of delirium, are slower to mobilise, have a longer hospital stay and poorer health-related quality of life [15] [16] [17] . Hung et al. advocate the importance of optimal pain control following hip fracture in order to minimise complications of pain and immobility ranging from delirium to functional loss and death [4] . Providing patients with effective analgesia has been shown to reduce delirium, with delirium being an independent risk factor for death, institutionalisation and dementia [18] [19] [20] [21] .
Analgesia-prescribing practices in hip fracture
Numerous studies indicate that elderly hip fracture patients are typically under-treated for pain [22] [23] [24] . In a large study of 646 elderly patients with hip found that undertreatment of pain was common and time to analgesia in this cohort was relatively slow [22] . Twenty-nine per cent of patients had no record of analgesia in the emergency department (ED), and half of these also received no pre-hospital analgesia. Of those who did receive some form of pain relief, intravenous (i.v.) morphine was the most common analgesia administered, although the median time to first analgesia was 75 min after arrival in the ED. The authors also commented on very limited utilisation of regional analgesia, with only 45 patients (7%) receiving a nerve block [22] . Cognitive impairment and communication difficulties were reported as the most common barriers to the provision of analgesia among the elderly [22] . Similar findings were observed in a US study, where it was found that 50% of older patients with moderate to severe pain following hip fracture received inadequate analgesia [23] . Those with advanced dementia were seen to receive one-third the amount of morphine sulphate equivalents as cognitively intact patients. Among the cognitively intact, 40% reported severe pain, suggesting that the majority of dementia patients, who received far less analgesia in comparison, were also in severe pain postoperatively even if unable to communicate this effectively [23] . Better methods of assessing and treating acute pain in the cognitively impaired patient are needed. Although some attempts are being made to develop specific, evidence-based guidelines for acute pain management in the cognitively impaired, implementation appears to be poor and current practices remain variable at best [24] .
Pain assessment practices Accurate and timely pain assessment is a critical component of optimal pain management. Evidence-based practice guidelines for the assessment of acute pain have been released by multiple bodies, including the Joint Commission on the Accreditation of Healthcare (JCAHO) [25, 26] , the Agency for Health Care Policy and Research (AHCPR) [27] and the American Pain Society (APS) [28] . Although pain assessment practices have been recognised internationally as one of the key quality indicators for geriatric emergency care [29, 30] , there is evidence that the implementation of pain assessment and re-assessment continues to be variable and inadequate among elderly trauma populations [31, 32] . This becomes particularly challenging among those with cognitive impairment, dementia or delirium, when commonly used self-report assessment tools are often uninformative [23, 33, 34] . For the assessment of pain in cognitively impaired or non-verbal patients, it is recommended that methods of behavioural observation be utilised [35, 36] . There is currently no international consensus on a standardised tool, although a number of validated alternatives are available including the Australian Abbey Pain Scale [37] endorsed by the Australian Department of Health [38] , and the American DS-DAT assessment [39] .
Opiate use for hip fracture in the elderly A retrospective, observational study conducted by White et al. identified that 36% of hip fracture patients have renal dysfunction on admission to hospital, with nearly 29% demonstrating grade-3 chronic kidney disease [40] . This cohort of patients is at high risk of morphine accumulation and subsequent over-sedation and respiratory depression, which can lead to respiratory tract infections and hypoxia. These are some of the reasons why the AAGBI guidelines suggest caution with opiate use in elderly hip fracture patients [6] . There is also some suggestion that opiate use may be associated with delirium in elderly patients [41] , although this association is not always consistent [24] . Hamrick and Meyer suggest that, other than meperidine, opiates are among the safe alternatives to give elderly patients without the risk of delirium [20] . It should be noted that untreated pain can itself trigger delirium [42] [43] [44] , thus a delicate balance must be achieved between effectively treating pain, and minimising the amount of opiates required to do so.
The role of regional nerve blockade for hip fracture Systemic analgesia poses significant challenges among physiologically frail, elderly trauma patients. Thus, there is growing interest in the role of regional anaesthesia and analgesia, particularly for this vulnerable patient population (for review, see [45] ). There is mounting evidence to support the use of regional nerve blocks for acute pain in the elderly, associated with a fractured hip. A recent Cochrane review supports the use of regional nerve blocks to reduce acute pain after hip fracture, with high-quality evidence showing that regional blockade reduces pain on movement within 30 min of block placement [46] . Femoral nerve blocks have been shown to effectively reduce pain associated with hip fracture, in a manner that is site-specific, rapid in onset and reduces the need for opiates and breakthrough analgesia. Benefits beyond effective analgesia have also been suggested, including reduced incidence of delirium, reduced hospital stay, decreased mortality, as well as ease of nerve block administration in ED or even the pre-hospital setting.
Reduced pain and opiate requirements
There is consistent evidence that nerve blocks can reduce pain associated with hip fracture. Numerous studies have demonstrated that nerve blocks can reduce pain scores significantly more than systemic analgesia [15, [47] [48] [49] . Abou-Setta's systematic review found statistically significant evidence that epidural (p < 0.001), fascia iliaca block (FIB) (p = 0.05), femoral nerve block (FNB) (p < 0.001), psoas compartment block (p = 0.002) and combined nerve blocks (p < 0.001), all provided superior analgesia to no block or standard care [15] . Among those studies reviewed, those that utilised ultrasound guidance and sampled a large patient population demonstrated the most significant positive effects of regional blockade. There is also consistent evidence that the use of regional nerve blocks can reduce the consumption of opiates following hip fracture [50] [51] [52] [53] [54] [55] [56] [57] , and reduce the incidence of opiate side-effects and overdose [53, [55] [56] [57] .
Improved positioning
The use of nerve blocks has been shown to increase hip flexion following hip fracture, and enable patients to sit more comfortably [58] . Blocks have also been shown to reduce pain during positioning for spinal anaesthesia [48, 59, 60] .
Delirium prevention
There is mounting evidence that the use of femoral nerve blocks can reduce the incidence of delirium in elderly subjects with hip fracture [57, [61] [62] [63] . AbouSetta's meta-analyses support this, identifying moderate strength evidence in favour of statistically reduced incidence of delirium with nerve blockades compared with no blockade [15] . This is likely multifactorial, and may reflect a number of factors including improved pain control, analgesic efficacy and reduced opioid consumption among those who receive nerve blockade. However, these findings have not been supported by a recent Cochrane review that was unable to identify sufficient high-quality evidence to conclusively demonstrate reduced incidence of delirium following the use of nerve blockade [46] . Given the promising primary evidence, further research in this area is a priority.
Reduced hospital length of stay
There is some evidence to suggest that nerve blocks may shorten hospital stay in fractured hip patients [50, 57] . One study found length of stay was reduced to a mean of 10 days among patients who received FIB, compared with 15 days for those who did not receive a block [50] . There is also some suggestion that the use of nerve blocks may accelerate patient rehabilitation and recovery following hip fracture. Morrison et al. reported that patients who received femoral nerve blocks walked further three days after surgery and had better mobility at six weeks, than those who received conventional analgesia only [55] . Moreover, Mangram et al. identified that a greater proportion of patients who received FIBs in addition to standard analgesic care were discharged home to their own residence, compared with those who received standard analgesic care alone (18.2% vs. 3.1%, respectively) [64] .
Reduced mortality and morbidity
There has been some suggestion that the use of nerve blocks may reduce inpatient mortality following hip fracture, however, evidence remains inconclusive. Lees et al. identified that inpatient mortality was significantly lower among patients who received FIB, than those who did not (5.5% vs. 15% (p = 0.0024), respectively) [50] . Similarly, Pederson et al. found that a comprehensive hip fracture programme that incorporated the use of continuous femoral nerve block catheters reduced 12-month mortality from 29% to 23%, although multiple factors likely contributed to this [65] . Overall, Abou-Setta's systemic review and metaanalysis could not identify a statistically significant reduction in mortality with nerve blocks based on limited available evidence, suggesting further investigation is needed.
In a similar vein, on the basis of limited available evidence, there was no statistically significant difference found with nerve blockade for cardiac complications, deep vein thrombosis, pulmonary embolism, myocardial infarction, nausea and vomiting, respiratory infection, stroke, surgical wound infection, urine retention or urinary tract infections in the systematic review conducted by Abou-Setta et al. [15] , although it was suggested that more studies in these areas are required. In Guay et al.'s recent Cochrane review, there is now moderate-quality evidence for a reduced risk of pneumonia following the use of nerve blocks [46] . In a study by Monzon et al., patients who received FIB reported fewer adverse events including delirium, nausea and vomiting, as compared with those who received i.v. non-steroidal anti-inflammatory drugs [62] . Foss et al. also reported that patients who received FIB were less sedated at 180 min after administration than those who received an intramuscular (i.m.) injection of morphine 0.1 mg.kg À1 [53] .
Patient satisfaction
Although rarely reported, patient satisfaction is another important consideration when evaluating pain management. A small study conducted by Diakomi et al. provides preliminary evidence that hip fracture patients who received FIB were more satisfied than those treated with i.v. fentanyl before positioning for spinal analgesia.
All patients who received a nerve block indicated that they would prefer to receive the same management in the event of a future operation, compared with only 25% of those who received i.v. fentanyl [60] . Table 1 provides an itemised summary of the prospective, randomised controlled studies published to date. For a full list of reviewed evidence, including cohort studies, retrospective studies and clinical audits, please see additional Table S1 included as Supporting Information.
Fascia iliaca block
The FIB is a relatively new form of femoral nerve block, whereby local anaesthetic is deposited deep to the fascia iliacus, lateral to the femoral artery and inferior to the inguinal ligament. With growing evidence that this is a safe, quick and easy to insert block [47, [66] [67] [68] [69] , FIBs are gaining popularity and becoming widely used for peri-operative pain relief in acute hip fracture, as seen by the increasing use of FIBs in the literature over the last decade [11, 70] . The FIB has been found to be comparable in effectiveness to older blocks such as the '3-in-1' femoral nerve block [71] , with now sufficient evidence to support that FIB can provide superior or equal pain relief to other forms of acute analgesia [72] . Rashiq et al. [18] suggest that different nerve blocks are more effective for particular outcomes. Specifically, the combination of obturator and lateral femoral cutaneous nerve (LFCN) blockade was the most effective against acute postoperative pain, whereas the FIB had the highest probability of being the most effective against delirium [18] . Results show a 70% reduction in delirium associated with fascia iliaca blockade. However, this study encompassed many trials that did not include patients with pre-operative cognitive impairment, arguably the group most likely to get delirium and the hardest in whom to detect delirium and pain. This review did not include studies that used ultrasound to locate the nerve or improve safety, and if performed optimally, it should block the obturator, LFCN and the femoral nerve. Newman et al. conducted a randomised controlled trial comparing analgesic efficacy of the FIB and the FNB for hip fracture patients [73] . Although they reported greater efficacy for FNBs, there has been criticism of the trial methodology and the techniques of block delivery (see related comments [74] [75] [76] [77] [78] [79] . In addition, this trial did not use ultrasound guidance, therefore, all three nerves may not have been blocked correctly, and the trial did not include patients with cognitive impairment, which may have resulted in an underestimation of the effect of the block on delirium.
Ultrasound guidance improves FIB safety and efficacy
It is clear that the use of appropriate methodology for FIB insertion is critical for maximising block safety and efficacy. There is substantial evidence and growing consensus around best-practice FIB protocols. It is now well accepted that ultrasound guidance improves both the safety and efficacy of FIB, with Cochrane and evidence-based guidelines identifying ultrasound guidance as the gold-standard localisation technique for regional nerve blocks [80] [81] [82] . Dolan et al. [83] performed a direct comparison of FIB when performed with ultrasound guidance, vs. a more rudimentary 'loss-of-resistance' or 'two-pop' technique. Ultrasound guidance resulted in significantly greater incidence of sensory loss in the medical aspect of the thigh (95% vs. 60%), and increased incidence of complete sensory loss in the anterior, medial and lateral thigh (82% vs. 47%). Ultrasound guidance also significantly increased the incidence of femoral and obturator nerve motor block [83] . In a similar trial, Abrahams et al. showed that ultrasound guidance was superior to peripheral nerve stimulation for FIB localisation, resulting in faster, safer and more successful FIB insertion [84] .
Barrington and Kluger provided evidence that ultrasound guidance for peripheral nerve blocks reduces the incidence of local anaesthetic systemic toxicity (LAST) with an odds ratio of 0.2 [85] . This corroborates earlier work [86] , including a study which showed that ultrasound guidance reduced unintentional vascular puncture, reduced block failure rates, decreased block performance time, reduced onset time to analgesia and facilitated longer duration of block [80, 84] .
Optimising fascia iliaca block safety using ropivacaine Evidence demonstrates that the FIB is a safe block to perform, with minimal documented accounts of sideeffects or complications. In an audit of two large European hospitals with 1586 fractured hip patients who received FIB, there were only two cases of true anaesthetic toxicity reported [50] . Ropivacaine is emerging as an anaesthetic agent of choice for optimal FIB safety. It has been shown to produce less potent motor blockade but equally effective sensory block as doseequivalent bupivacaine [87] . Studies of i.v. ropivacaine infusion in healthy volunteers have also demonstrated superior tolerance and less cardiac and central nervous system toxicity associated with ropivacaine compared with bupivacaine [88, 89] .
Bleckner et al. tested serum ropivacaine concentrations and LAST in trauma patients with continuous peripheral nerve block catheters [90, 91] . They found that no patients demonstrated clinical signs of systemic ropivacaine toxicity, even two patients who demonstrated isolated serum ropivacaine concentration spikes into a previously identified toxic range. In addition, they found that the total duration of local anaesthetic infusion did not seem to influence the free concentration of the drug, despite infusion times of up to 27 days. For elderly fractured hip patients, the ED 50 and ED 95 of 30 ml of levobupivacaine were very low (0.026% and 0.036% w/v, respectively) [92] , thus, if the correct doses are used, the chance of reaching toxic levels in these patients is extremely rare. Correct dosage combined with ultrasound guidance will further decrease the risk of harm as suggested in most guidelines [11, 70, 93] .
Fascia iliaca block for early pre-operative analgesia Making it particularly attractive for use in the emergency and acute trauma setting, research has demonstrated that practitioners other than specialist anaesthetists can safely administer FIB in EDs and pre-hospital settings. In a recent trial, McRae et al. found that paramedics could safely administer FIB to hip fracture patients at the scene of their injury, with better pain reduction after 15 min compared with patients who received standard analgesic care (50% vs. 22%, p = 0.025). Importantly, this did not increase scene times or cause any adverse effects [66] . Dochez et al. showed that emergency medical service nurses could safely administer FIBs to hip fracture patients during pre-hospital care with a success rate of 96%, resulting in marked reduction in pain scores and no complications noted [68] . The work of Obideyi et al. has also demonstrated that with appropriate training, nurses can safely and effectively administer FIBs [94] .
Numerous audits and trials have demonstrated safety and improved patient outcomes when FIBs are administered to hip fracture patients in the ED [52, 69, 95] . This includes blocks that are administered by well-trained junior medical staff in addition to more senior specialists [47, 96] .
Nerve blocks as part of a comprehensive analgesia protocol
It is evident there are multiple treatment components that can improve outcomes for the frail hip fracture patient. Packaged care plans and protocol-driven, timely treatments are advised, with multiple guidelines recommending specialist pain treatment protocols combined with early specialist geriatric input and surgery within 48 h [97] [98] [99] [100] [101] . Immediate admission of elderly hip fracture patients to an orthogeriatric service has been shown to improve patient outcomes, including mobility at 4 months [102] . Dedicated clinical pathway use has also been shown to lower the odds of four common complications of hospitalisation after hip fracture: deep vein thrombosis, pressure ulcers, surgical site infection and urinary tract infection [103] . Multidisciplinary models of orthogeriatric care can improve outcomes and decrease inpatient complications following hip fracture, particularly for the elderly [104] [105] [106] [107] . Integrating the orthogeriatrician into the care plan for hip fracture patients provides an opportunity to identify and reduce risk factors pertinent to these frail patients at risk of delirium and other common geriatric complications, while monitoring for poly-pharmacy and drug interactions that may occur during pain management in the acute peri-operative period. United Kingdom and Australian guidelines suggest that the use of regional nerve blocks can be well integrated into comprehensive pain pathways [6, 10] . Ultimately, the use of streamlined, comprehensive pain protocols that integrate timely pain assessment, the use of regional nerve blocks and specialist geriatric input promise to provide the greatest combined benefits to acute pain management, the quality of patient care and subsequent morbidity and mortality (Table 2) .
Discussion
This narrative review identified Level-1 and Level-2 evidence for using regional nerve blocks to provide analgesia after hip fracture, including two meta-analyses and a number of prospective randomised controlled trials (Table 1 ). The majority of available literature provided Level-3 evidence [14] , including Anaesthetic agent of choice
Ropivacaine has a lower incidence of cardiac and/or nervous system toxicity as compared to bupivacaine. Systemic toxicity has not been witnessed in adult trauma patients receiving continuous ropivacaine infusion via catheter.
Knudsen et al. [88] Bleckner et al. [90] , [91] cohort studies, pseudorandomised or uncontrolled trials, and retrospective analyses. In these studies, quantitative outcome measures of analgesic efficacy (such as pain scores and recorded opiate use), the complications of untreated acute pain (including the incidence of delirium, mortality and other morbidity), and indicators of system efficiency (such as hospital length of stay and adherence to analgesic guidelines) were often only partially explored. Cowan et al.'s recent literature review supports the suggestion that regional blockade be considered for all those with fractured hips, but acknowledges that pain relief must be individualised and further research is warranted [13] . Of note, it would be beneficial to further explore the cost analysis of a reduction in delirium in the elderly which is known to extend length of stay. It would also be of interest to extend studies examining mortality and to explore prospectively the incidence of surgical complications and falls which may be of great benefit to surgeons, departments of pain medicine and hospital administrators. However, there is sufficient evidence to support that regional nerve blocks provide effective analgesia and reduce the need for opiates among the elderly with hip fracture.
A recent Cochrane review explored the use of nerve blocks for the management of hip fracture pain in the pre-operative, intra-operative and postoperative periods [46] . It included all types of blocks including triple blocks, obturator blocks and others inserted using a variety of techniques including ultrasound, nerve stimulation and anatomical landmarks alone. This review identified improvements in pain on movement, the risk of pneumonia and the costs of analgesia following the use of nerve blocks. Due to a rigorous review protocol and strict inclusion criteria however, only 31 out of 1116 identified articles were included. As a result, meta-analyses on acute confusional states and mortality lacked sufficient power and thus definitive conclusions about the impact of nerve blocks on these outcomes could not be drawn.
Regarding the translation of evidence into practice, a number of important considerations have been raised in the literature related to the use of regional nerve blockade for acute pain of hip fracture in the elderly. These include local resource considerations, such as the availability of equipment in the ED including ultrasound, the provision of easy to use regional blockade kits, the level of training and confidence among emergency medical and nursing staff in the administration of nerve blocks, and often a lack of training in pain assessment protocols for the elderly, delirious and demented. There are also system-wide considerations, which can include a lack of hospital guidelines for analgesia in the elderly that incorporate regional blockade, the pressures on ED staff to process and discharge patients to the ward as soon as possible, and often a widespread exclusive reliance on parenteral and oral opioids to treat acute pain in the elderly.
To facilitate the translation of evidence into practice, these issues need to be addressed with support from administrators, policy makers, clinicians and funders. Education and training is vital to ensure that knowledge, confidence and competency in best-practice nerve block techniques remain high among emergency staff [51, [108] [109] [110] . Identifying local champions, trainers and auditors could be a useful way to initiate change and shift thinking from a universal reliance on opiates for the management of acute pain in the elderly [54, 108] . The development of specific clinical pathways and protocols for the treatment of pain in the elderly have also been shown to be effective [50, 57, 107] , acknowledging the different physiology and analgesic requirements of this vulnerable group.
Conclusions
Nerve blocks such as FIB for the elderly hip fracture patient should be integrated into routine multi-modal acute pain management protocols. They have been shown to effectively reduce acute pain, the need for opiates, decrease the incidence of delirium, and potentially have further consequent benefits for morbidity, mortality and quality of life. Continued research is needed to quantify the extent of these benefits and elucidate whether other peri-operative complications may also be reduced by the use of nerve blocks. Targeted education and training programmes will be important to increase clinician awareness, confidence and competency in block techniques and ensure evidence-based acute pain guidelines are effectively translated into clinical practice.
